Clinical trial
Acamprosate in Alcoholics With Comorbid Anxiety or Depression
NCT00330174 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00330174 |
|---|---|
| Title | Acamprosate in Alcoholics With Comorbid Anxiety or Depression |
| Official title | The Use of Acamprosate in Individuals With Alcohol Dependence and Comorbid Anxiety or Depression |
| Lead sponsor | Medical University of South Carolina, Other |
| Collaborators | Mclean Hospital Columbia University |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alcohol Dependence, Major Depression, Social Anxiety Disorder, Generalized Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Acamprosate |
| Enrollment | 90 |
| Start date | Apr 1, 2006 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | May 26, 2006 |
| Last update posted | Apr 13, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: